#Moderna booster


People who got the Moderna vaccine may soon be eligible for COVID boosters

FDA advisers vote unanimously on recommending that the agency authorize Moderna's COVID-19 vaccine boosters. The agency will consider Johnson & Johnson's booster authorization request on Friday. A MARTINEZ, HOST:. Millions of people who got the Moderna vaccine could soon be eligible for a booster. A Food and Drug Administration advisory...

NIH study of COVID-19 vaccine boosters suggests Moderna or Pfizer works best

The long-awaited study finds that people who got the J&J vaccine would benefit more from getting a Pfizer or Moderna vaccine as their booster instead of another J&J shot. There's a new study from the National Institutes of Health that suggests those who got the Johnson & Johnson shot could mix things up when getting a booster. Joining us now to explain it all is NPR health correspondent Rob Stein. Rob, a lot of people thinking about getting boosters probably assume they'd get the same vaccine as the original dose. I'm right there along with them. What did the study find?

University Health executive sounds off on the FDA's endorsement of Moderna's COVID-19 booster

KANSAS CITY, Mo. — Thursday, a Food and Drug Administration advisory panel unanimously endorsed Moderna’s proposed booster shots. Local Kansas City area doctors gave their thoughts on the recommendation. “They always base their recommendations on what the data reveals,” University Health Chief Clinical Officer Dr. Mark Steele said. University Health...

Moderna COVID vaccine booster shot update: New FDA panel details to know

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites. After the Food and Drug Administration gave the thumbs up to a Pfizer COVID-19 vaccine booster shot, an FDA independent advisory committee on Thursday recommended a booster shot of Moderna's vaccine. The recommendation now goes to FDA officials to consider.

Moderna, J&J Booster Shots: When the FDA Could Make a Decision

Both Moderna and Johnson & Johnson have submitted requests for emergency use authorization of their booster shots of the COVID vaccines, but when could federal regulators make a decision?. The FDA is convening its outside panel of advisers next week to review booster data from both J&J and Moderna. It’s...

FDA Panel Recommends Moderna Booster Shot for Same Groups as Pfizer

A panel of scientific experts that advises the Food and Drug Administration voted unanimously Thursday that the agency recommend people 65 and over, people 18 to 64 at risk of severe COVID-19 complications due to illness, and people whose jobs put them at risk of infection receive third shots of the Moderna coronavirus vaccine. The agency recommended the same groups receive booster shots of the Pfizer vaccine. The Vaccines and Related Biological Products Advisory Committee voted 19-0 to make the recommendation. The guidance is not binding, though the FDA is expected to follow it. The panel has not made a recommendation for when those outside of the specific groups should get a third shot.

FDA advisers recommend Moderna booster shot for at-risk adults

Today, the FDA's vaccine advisers recommended that the agency authorize booster shots for the Moderna vaccine for people at high risk of COVID-19. The vote was unanimous, and it came after a full day of discussions on the safety and efficacy of booster shots. NPR's Pien Huang monitored the meeting, and she joins us now. Hello.
NBC Chicago

Johnson & Johnson, Moderna and Pfizer: What We Know About Booster Shots So Far

Johnson & Johnson released a new update on the potential for a booster shot of its single-dose coronavirus vaccine Tuesday, but as booster shots continue to be debated nationwide, what's next for all three COVID vaccines currently being administered in the U.S.?. Pfizer, Moderna and J&J have each conducted studies...

Kokua Line: When will the Moderna booster shot be ready?

Question: When will the Moderna booster shot be approved?. Answer: In about two weeks or so, if federal officials give the go-ahead, and on the same review timeline as the Pfizer-BioNTech booster shot received. The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is scheduled...